Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 YearsStephanos J. Hadziyannis, Steven L. Chuck, Nicolaos C. Tassopoulos et al.|Gastroenterology|2006Cited by 882
Viral Quasi-Species Evolution During Hepatitis Be Antigen SeroconversionSeng Gee Lim, Allen G. Rodrigo, Yan Cheng et al.|Gastroenterology|2007Cited by 128
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 CountriesJin-Lin Hou, Seng Gee Lim, Yu‐Ming Wang et al.|Clinical Gastroenterology and Hepatology|2019Cited by 111
P.102 Long-term adefovir dipivoxil treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B: results after 5 years of therapyS. Hadziyannis, Steven L. Chuck, N.C. Tassopoulos et al.|Journal of Clinical Virology|2006Cited by 59
World Gastroenterology Organisation Global Guideline Hepatitis BJordan J. Feld, Anton LeMair, Harry L.A. Janssen et al.|Journal of Clinical Gastroenterology|2016Cited by 21